Literature DB >> 29687845

miRNA-21 promotes gastric cancer growth by adjusting prostaglandin E2.

R Qi1, D-T Wang, L-F Xing, Z-J Wu.   

Abstract

OBJECTIVE: It is to study the stimulation and possible active mechanism of miRNA-21 on AGS proliferation of gastric cancer.
MATERIALS AND METHODS: AGS gastric cancer cells were cultivated in vitro and then divided into the blank control group, the PGE2 (prostaglandin E2) group, the anti-miRNA-21 group and the PGE2 + anti-miRNA-21 group and the MTT and the flow cytometry methods were adopted to test the effect of PGE2 or/and anti-miRNA-21 intervention on AGS cell proliferation and apoptosis and the differences to miRNA-21 expression. In addition, the cells were also divided into the blank control group, the PGE2 group, the PGE2 + Perifosine group, the PGE2 + anti-miRNA-21 group and the PGE2 + anti-miRNA-21 + Perifosine group and the MTT and flow cytometry methods were adopted to test the effect of Perifosine intervention on AGS cell proliferation and apoptosis and on PTEN and p-AktmRNA and protein expressions.
RESULTS: Compared with the control group, AGS cell proliferation activity increased significantly, the apoptosis rate decreased and the miRNA-21tmRNA and protein expression increased in the PGE2 group (p < 0.05); compared with the PGE2 group, the AGS cell proliferation rate decreased, the apoptosis rate increased and the miRNA-21mRNA and protein expressions decreased (p < 0.05) in the anti-miRNA-21 group and the PGE2 + anti-miRNA-21 group. In addition, after intervention of Perifosine, the AGS cell proliferation rate decreased, the apoptosis rate increased, the PTEN mRNA and protein expressions increased and the pAktmRNA and protein expressions decreased (p < 0.05).
CONCLUSIONS: miRNA-21 may promote the growth of gastric cancer cells by adjusting and controlling PTEN/Akt signal passage mediated PEG2.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29687845     DOI: 10.26355/eurrev_201804_14717

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP.

Authors:  Zixuan Gong; Xiaoyu Chen; YueChao Zhang; Cheng Liu; Zhibing Wang; Xiaoyan Xu; Jun Zhu; Tongqing Xue
Journal:  Cancer Manag Res       Date:  2020-09-29       Impact factor: 3.989

2.  MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.

Authors:  Bo Fan; Yiying Jin; Hongshuo Zhang; Rui Zhao; Man Sun; Mengfan Sun; Xiaoying Yuan; Wei Wang; Xiaogang Wang; Zhiqi Chen; Wankai Liu; Na Yu; Qun Wang; Tingjiao Liu; Xiancheng Li
Journal:  Int J Oncol       Date:  2019-12-02       Impact factor: 5.650

3.  CircRNA_0043691 sponges miR-873-3p to promote metastasis of gastric cancer.

Authors:  Yu Zhang; Gengyuan Hu; Zhenxing Zhang; Yuanming Jing; Feng Tao; Minfeng Ye
Journal:  Mamm Genome       Date:  2021-08-09       Impact factor: 2.957

4.  MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway.

Authors:  Yuhua Zhang; Xiaobo Qin; Juan Jiang; Wenjie Zhao
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

Review 5.  Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways.

Authors:  Haijun Wang; Ke Zhang; Jia Liu; Jie Yang; Yidan Tian; Chen Yang; Yushan Li; Minglong Shao; Wei Su; Na Song
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

6.  The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis.

Authors:  Weiwei Yuan; Jinxi Huang; Shanshan Hou; Huahua Li; Liangyu Bie; Beibei Chen; Gaofeng Li; Yang Zhou; Xiaobing Chen
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.